About Osiris
Osiris is a company based in Baltimore (United States) founded in 1992 was acquired by Smith & Nephew in March 2019.. The company has 356 employees as of December 31, 2018. Osiris operates in a competitive market with competitors including Horizon Therapeutics, Histogenics, Mesoblast, Osteal Therapeutics and Enobia Pharma, among others.
- Headquarter Baltimore, United States
- Employees 356 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Osiris Therapeutics, Inc.
-
Annual Revenue
$142.82 M21as on Dec 31, 2018
-
Net Profit
-
EBITDA
$9.85 M595as on Dec 31, 2018
-
Latest Funding Round
- Investors
-
Employee Count
356
as on Dec 31, 2018
-
Acquired by
Smith & Nephew
(Mar 12, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Osiris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Osiris
Osiris has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Smith & Nephew. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of knee, hip and shoulder joint replacements
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Osiris
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Osiris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Osiris Comparisons
Competitors of Osiris
Osiris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Histogenics, Mesoblast, Osteal Therapeutics and Enobia Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Restorative cell therapies for orthopedic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics derived from proprietary adult stem cell-based technologies
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
|
|
| domain | founded_year | HQ Location |
Therapies for genetic metabolic bone disorders are developed.
|
|
| domain | founded_year | HQ Location |
Cellular therapeutics are developed for cancer, orthopaedics, and COPD.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Osiris
Frequently Asked Questions about Osiris
When was Osiris founded?
Osiris was founded in 1992.
Where is Osiris located?
Osiris is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
How many employees does Osiris have?
As of Dec 31, 2018, the latest employee count at Osiris is 356.
What is the annual revenue of Osiris?
Annual revenue of Osiris is $142.82M as on Dec 31, 2018.
What does Osiris do?
Osiris Therapeutics was founded in 1992 in Baltimore, United States, based on stem cell technology from Case Western Reserve University. Operations focus on biotechnology within regenerative medicine, including bioengineering and viable tissue products. Commercial products such as BIO4, Cartiform, and Grafix are provided for orthopaedics, sports medicine, and wound care. Research and development continue to advance stem cell applications.
Who are the top competitors of Osiris?
Osiris's top competitors include Horizon Therapeutics, RoosterBio and Mesoblast.
Who are Osiris's investors?
Osiris has 1 investor. Key investors include Smith & Nephew.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.